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Abstract
Primary angiosarcoma of the breast is a rare tumour that account for fewer than 0.05% of all malignant mammary
tumours. Angiosarcoma may have an perfidious clinical onset. Radiologic findings are often nonspecific and may
appear completely normal in one-third of cases with primary angiosarcoma. The prognosis is usually poor because
of the high rates of local recurrence and early development of metastases. Aggressive surgical resection is the
mainstay of treatment. The role of adjuvant therapy has not yet been well established.
Here we present a case of a 53 year old, postmenopausal women with primary angiosarcoma arising in
fibroadenoma. To our knowledge, this is the first case described in the literature to date.
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Background
Angiosarcoma is a rare malignancy of endovascular ori-
gin. Skin and superficial soft tissue are the most com-
mon locations that become involved. This is in contrast
with the deeper location of other soft tissue sarcomas.
Less frequently it can occur in various organs and has
been reported in uterus [1], ovary [2], small intestine
[3], lung [4], heart [5], oral cavity [6], orbit [7] and thyr-
oid [8]. Unlike angiosarcomas of the skin, deep angiosar-
comas more commonly have an epitheloid appearance
consisting of nests and clusters of round cells of high
nuclear grade. These so called epitheloid angiosarcomas
consists of sheets of highly atypical round cells with
prominent nuclei, some of which contain intracytoplas-
mic lumens.
Primary soft tissue sarcomas represent fewer than 1%
of primary breast malignancies. Angiosarcomas are rare
and highly aggressive tumours that account for fewer
than 0.05% of all malignant mammary tumours [9].
They may arise spontaneously (as a primary malignancy)
or as a sequel of radiation therapy and postoperative
lymphedema due to breast cancer (secondary). In com-
parison, primary angiosarcomas are relatively rarer, they
tipically occurs in younger women and arise from breast
parenchyma. Secondary angiosarcomas usually occurs in
elderly women, arise from skin and show a pattern of
infiltration into breast parenchyma from skin and sub-
cutis. Both primary and secondary breast angiosarcoma
carry a prognosis worse than mammary carcinoma [10].
Synchronous bilateral angiosarcoma has been reported
[11], although the contralateral breast is a common site
of metastasis and such cases may potentially represent
metastatic spread. Primary breast angiosarcoma has also
been described in conjunction with synchronous pri-
mary breast carcinoma [12,13] and also with silicone
granuloma after breast augmentation [14].
Fibroadenomas are the most common benign tumors
of the female breast. They are most frequent in young
women, mainly those under 30 years, but may be seen
at any age. These tumours are characterized by a prolif-
eration of both stromal and epithelial elements of the
breast. Fibroadenoma may be associated with fibrocystic
changes, calcifications, proliferative epithelial changes,
and extremely rarely, lobular and ductal non-invasive
and invasive carcinoma may occur within fibroadenoma
[15].
Angiosarcoma arising in fibroadenoma has not been
documented so far, to the best of our knowledge. Only
o n ec a s eo fa n g i o s a r c o m aa r i s i n gi nar e c u r r e n tp h y l -
lodes tumor has been published [16]. Here we present a
case of a 53 year old women with primary angiosarcoma
arising in fibroadenoma.
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A 53-year old postmenopausal female presented with a
lump in the upper outer quadrant of her right breast. At
physical examination a mass was palpable, painless, firm
and not fixed to the underlying structure. There was no
history of pain or nipple discharge. Overlying skin was
unremarkable. The patient had not received any radio-
therapy in the past. Any family history of breast malig-
nancies was denied.
Mammography revealed two well circumscribed nodu-
lar formations in the upper outer quadrant of right
breast. The contours were smooth, with high density
and homogeneous. The conclusion of radiologist was
benign finding (BI-RADS 2).
Ultrasonography revealed macrolobulated complex
formation measuring in diameter 41 mm. The ultraso-
nography guided core needle biopsy was also taken.
Pathologic examination of this sample showed fibroade-
noma (Figure 1).
After 6 months, a lump in breast progressively
increased in size to a size of 80 × 35 mm. The patient
did not complain of tenderness or pain. There was no
history of nipple retraction or discharge. Overlying skin
was unchanged. No axillary or supraclavicular lymph
nodes were palpable. The contralateral breast and axilla
were normal.
Lumpectomy was suggested. On gross examination, the
specimen consisted of a fibrofatty piece of tissue measuring
5 × 5 × 4.5 cm. On sectioning there was a lobulated, partly
soft and hemorrhagic, incapsulated nodule measuring 4 cm
in diameter. Microscopy revealed a tumor to be a fibroade-
noma with pericanalicular and intracanlicular patterns of
growth and with stromal hyalinization. Within the tumor
there was one focus composed of marked proliferation of
poorly formed, thin-walled vascular channels lined with
highly atypical endothelial cells. Necrotic foci with marked
hemorrhage and relatively solid proliferation of polygon-
ally-shaped and spindle atypical endothelial cells were seen.
Prominent tufts and papilations composed of enlarged,
polygonally-shaped, highly malignant endothelial cells, with
brisk mitotic activity, was also observed (Figure 2). The
endothelial cells had abundant cytoplasm with spindle-
shaped or round nuclei and showed either a papillary or
solid growth pattern. A panel of immunohistochemical
markers was performed. The neoplastic endothelium was
diffusely and strongly reactive for CD31. With CD34
immunostain parts of the tumor were strongly positive
(Figure 2), while in poorer differentiated areas, with epithe-
loid and solid appearance almost completely negative. The
neoplastic cells were negative for pan cytokeratin clone
MNF 116 and desmin. In addition, proliferative activity
was determined using monoclonal antibody Ki-67/MIB-1.
Ki-67 proliferative activity in fibroadenoma was 4% and in
part of the lesion with malignant endothelial cells 57% (Fig-
ure 3). A diagnosis of high-grade angiosarcoma arising in
fibroadenoma was made. Radical mastectomy was per-
formed subsequently and no residual tumour was found.
Cysts with epithelial lining showing apocrine metaplasia,
sclerosing adenosis with microcalcifications and additional
fibroadenoma measuring 3 mm in diameter was observed
in the adjacent breast tissue.
The postoperative course was uneventful. After the
operation extensive clinical evaluation was performed to
exclude potential metastatic processes. All test results
were normal. Eight months after the surgery the patient
is free of recurrence and metastasis.
Discussion
Angiosarcoma of the breast, including primary and
secondary type, remain rare malignancy. Although,
Figure 1 Core needle biopsy specimen of the breast showing fibroadenoma. (HE), 40 × (A), 100 × (B).
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body, they rarely arise from major vessels and have a
predilection for skin and supreficial soft tissue. When
it occurs in the breast, it affects women during the
third and fourth decades of life. The etiology of pri-
mary angiosarcoma is still unresolved. Twelve percent
of the cases are found during pregnancy, implaying a
hormonal effect [17]. In contrary our patient was
slightly older post-menopausal women. There are no
known risk factors for developing primary angiosarco-
mas, but it has been reported adjacent to foreign mate-
rials. There has been a report of development breast
angiosarcoma adjacent to silicone granuloma in a
patient who underwent breast augmentation with sili-
cone implants [14]. An extuberant host response in the
form of a fibrous tissue capsule around the foreign
Figure 2 Microscopic features of the resected tumor. Fibroadenoma of the breast HE, 100 × (A). Fibroadenoma and angiosarcoma in the
same field, HE, 20 × (B). Angiosarcoma, the tumor is highly vascular with relatively solid spindle cell proliferation and area of stromal
hemorrhage, HE, 100 × (C). Prominent tufts and papilations composed of enlarged highly malignant endothelial cells with brisk mitotic activity,
HE, 200 × (D). Immunohistochemical stain for vascular marker CD34 was positive in angiosarcoma and negative in fibroadenoma, 40 × (E). Highly
malignant endothelial cells, HE, 400 × (F).
Figure 3 Immunohistochemical staining with monoclonal antibody Ki-67/MIB-1. Ki-67 proliferative activity in fibroadenoma, 40 × (A); and
in angiosarcoma, 40 × (B).
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in the development of the angiosarcoma. The prog-
nosis of primary angiosarcoma is usually poor because
of the high rates of local recurrence and early develop-
ment of metastases [18]. Angiosarcoma of the breast
has a tendency to metastasize hematogenously, the
regional lymph node involvement is uncommon either
at presentation or at recurrence [19]. The most com-
mon sites of metastasis are lung, bone, liver and skin.
Angiosarcoma may have an perfidious clinical onset,
presenting as a painless often discrete mass that grows
rapidly. Radiologic findings are often nonspecific, and
angiosarcoma may easily be overlooked. Mammograms
may show a nonspecific mass and may appear comple-
tely normal in one-third of cases with primary angio-
sarcoma. Visible masses may be ill-defined or
circumscribed, and may be round to oval or more
lobulated. Associated coarse calcifications may be pre-
sent [20]. Luini et al reported that most authors report
normal mammographic findings in cases of primary
angiosarcoma [9]. Ultrasonography tends to be nonspe-
cific. The diagnosis of primary angiosarcoma of the
breast may be challenging. The main differential diag-
noses of high-grade angiosarcoma are metaplastic car-
cinoma with angiosarcomatous differentiation and
other poorly differentiated sarcomas. Histologically, the
presence of characteristic lower-grade angiosarcoma at
the periphery of the lesion can be helpful in diagnosis.
In our case peripheral parts of tumor were composed
of poorly formed, thin-walled vascular channels lined
with highly atypical endothelial cells. Similarly, meta-
plastic carcinomas may be associated with DCIS or
areas of typical invasive carcinoma of ductal type. The
use of immunohistochemical markers for endothelium,
CD31, CD34 and factor VIII, confirm most angiosarco-
mas including poorly differentiated ones. As in our
case, usually in angiosarcomas CD34 highlights mainly
the uninvolved background vessels, and in fact, there
are different reports that have shown variable reaction
patterns to CD34 ranging from completely negative to
approximately 80% positivity of the neoplastic cells
[21]. In our patient, the intense reaction was seen in
peripheral areas of neoplastic lasion and in uninvolved
vasculature, while in poorer differentiated, solid areas
there was no immunoreactivity with CD34. CD31 is
the most specific marker for endothelial differentiation,
whereas CD34 is more sensitive. In our case a diagno-
sis of high grade angiosarcoma was confirmed by
strong and diffuse positive reaction for CD31, along
with negative cytokeratin and desmin stains. So the
diagnosis of metaplastic carcinoma and possible com-
bined myovascular lesions were ruled out. Moreover, a
Ki-67 proliferative score of 57% along with marked
pleomorphisam of endothelial cells are striking features
in favour of high grade malignancy.
Primary breast angiosarcomas are a heterogeneous
group of lesions histologically, composed of interanasto-
mosing vascular channels lined by hyperchromatic
endothelial cells, occurring within the breast parench-
yma. Angiosarcomas of the breast can be classified into
three main growth patterns, well-differentiared (Grade I)
to poorly differentiated (Grade III) tumors. The cells of
the low grade angisarcoma resemble endothelium, while
in majority of high grade angisarcoma endothelial tuft-
ing and papillary formations are prominent and the
endothelial cells show marked cytological atypia with
prominent nucleoli and frequent mitotic figures as in
our case. Haemorrhage into the surrounding stroma
(„blood lakes”) and areas of necrosis may be present.
However, variations in growth pattern are commonly
found within a single lesion; in particular, high-grade
lesions can have lower-grade areas at their peripheral
and superficial aspects. It was believed that histologic
g r a d ei so fp r o g n o s t i ci m p o r t a n c e ,b u tar e c e n ts t u d y
show that there is no correlation between histologic
grade and patients outcome [22]. The prognostic factors
of breast angiosarcoma include the tumor size, presence
of residual disease, cellular pleomorphism and prolifera-
tive index [23,24]. Aggressive surgical resection is the
mainstay of treatment. Even tought angiosarcoma at
other sites often involve regional lymph nodes [25], in
breast angiosarcoma the regional lymph node involve-
ment is uncommon either at presentation or at recur-
r e n c e[ 1 9 , 2 5 , 2 6 ] .T h er o l eo fa d j u v a n tt h e r a p yw i t h
radiotherapy and chemotherapy has not yet been well
established. A recent study reported a case of complete
response to adjuvant thalidomide therapy [27]. The
aggressive nature of this disease require exploration of
new adjuvant therapy regimens.
Conclusions
The rarity of primary angiosarcoma, unusual presenta-
tion of our case and possible diagnostic pitfalls associated
with poor prognosis emphasizes the need for systemic
presentation of these tumors in order to help pathologists
and clinicians to know that such an entity can initially
present as fibroadenoma. The aggressive nature of this
disease demands careful follow-up of these patients, due
to rarity of the condition the appropriate strategies of
treatment remain to be determined. The question
remains should we consider less aggresive terapeutic
approach for small lesions diagnosed microscopically?
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